Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation

Abstract

TMVr may improve short- and intermediate-term mortality in high-risk patients with cardiogenic shock and moderate to severe MR. Randomized studies are needed to definitively establish MR as a therapeutic target in patients with cardiogenic shock.